Tao Selected for METAvivor Early Career Investigator Award
Wei Tao, PhD
Wei Tao, PhD, of the Center for Nanomedicine and the Department of Anesthesiology, Perioperative and Pain Medicine, received the METAvivor Early Career Investigator Award from the METAvivor Foundation for his research project entitled “Multi-Staged Delivery System Overcoming the Physiological Barriers for Metastatic Breast Cancer (MBC) Therapy.”
METAvivor, which is the only U.S. organization that exclusively funds MBC research through a scientific peer-review process, awards research grants to individuals who are actively engaged in areas of MBC research and whose proposals show distinct promise in making a difference for patients with stage 4 breast cancer.
With the support of this award, Tao will develop a novel, multi-staged platform that he expects to deliver the ultimate "home-run" in a drug-delivery system with long blood circulation, high tumor accumulation, deep tumor penetrability and specific tumor-cell targeting — culminating eventually in safer, more effective MBC treatment.
METAvivor is dedicated to the specific fight of women and men living with stage 4 MBC.